Literature DB >> 28114714

[Adjunctive pharmacotherapy for acute respiratory distress syndrome].

Matthias Hecker, Markus A Weigand, Konstantin Mayer.   

Abstract

Acute respiratory distress syndrome (ARDS) is still regarded as an enormous medical challenge due to its complexity and poor prognosis. In spite of progress in research and therapy lethality remains unacceptably high. Besides established interventiotnal treatment options, numerous pharmacological approaches have been investigated in the past decades. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28114714     DOI: 10.1055/s-0042-105943

Source DB:  PubMed          Journal:  Dtsch Med Wochenschr        ISSN: 0012-0472            Impact factor:   0.628


  1 in total

1.  [52-year-old female with community-acquired pneumonia, acute respiratory distress syndrome : Preparation for the medical specialist examination: Part 25].

Authors:  A Güldner; P Spieth
Journal:  Anaesthesist       Date:  2019-04       Impact factor: 1.041

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.